Efficacy and safety of orthokeratology to control myopia in Asia children: A Meta-analysis
Author:
Fund Project:

National Natural Science Foundation of China(No.81373381)

  • Article
  • | |
  • Metrics
  • |
  • Reference [23]
  • | | | |
  • Comments
    Abstract:

    AIM: To assess the efficacy and safety of orthokeratology for reducing the progression of myopia in Asia children.

    METHODS: Seven databases, including the Cochrane Library, Medline, EMbase, CBM, CNKI, VIP, and WanFang Data, were searched. The published languages were limited to English and Chinese. The risk bias tool provided by Cochrance cooperation and methodological index for non-randomized studies(MINORS)scale were used to assess the risk bias of included studies(randomized controlled trials and controlled trials). The published biases of included studies were assessed with funnel plot. Meta-analysis was performed with Review Manager 5.3.

    RESULTS: Seven eligible studies, including 478 children, were included, 250 cases in ortho-k group, 228 cases in control group. The Meta-analysis indicated that change in axial length of ortho-k group was significantly less than the control group \〖WMD=-0.31, 95%CI(-0.35, -0.26), P<0.001\〗. Five studies observed adverse effects which all included the effect of positive staining of corneal fluorescein. One study reported chalazion in one child. None of the studies reported severe adverse events.

    CONCLUSION: The overall findings suggested that orthokeratology might slow the progression of myopia in children of Asia.

    Reference
    1 Foster PJ,Jiang Y. Epidemiology of myopia. Eye 2014; 28(2):202-208
    2 Fredrick DR.Myopia. BMJ 2002; 324(7347):1195-1199
    3 Pan CW,Ramamurthy D,Saw SW,et al. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiological Optics 2012; 32(1):3-16
    4 Rudnicka AR,Kapetanakis V,Wathern AK,et al. Global variations and time trends in the prevalence of childhood myopia: a systematic review and meta-analysis. Lancet 2015; 386:S69
    5 Dolgin E.The myopia boom. Nature 2015; 519(7543):276
    6 Si JK,Tang K,Bi HS,et al. Orthokeratology for myopia control:a meta-analysis. Optom Vis Sci 2015; 92(3):252-257
    7 Sun Y,Xu F,Zhang T,et al. Orthokeratology to control myopia progression:a meta-analysis. PloS One 2015; 10(6):e0130646
    8 Higgins JPT,Green S.Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Book Series 2008 Online
    9 Slim K,Nini E, Forestier D, et al. Methodological index for non-randomized studies(minors): development and validation of a new instrument. Anz J Surg 2003; 73(9):712-716
    10 Charm J, Cho P.High myopia-partial reduction ortho-k:a 2-year randomized study. Optom Vis Sci 2013; 90(6):530-539
    11 Chen C, Cheung SW, Cho P.Myopia control using toric orthokeratology(TO-SEE study). Invest Ophthal Vis Sci 2013; 54(10):6510
    12 Kakita T,Hiraoka T,Oshika T.Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthal Vis Sci 2011; 52(5):2170-2174
    13 Cho P,Cheung SW.Retardation of myopia in Orthokeratology(ROMIO)study:a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci 2012; 53(11):7077-7085
    14 Cho P,Cheung SW,Edwards M.The longitudinal orthokeratology research in children(LORIC)in Hong Kong:a pilot study on refractive changes and myopic control. Curr Eye Res 2005; 30(1):71-80
    15张春燕, 高莉莉,辛向阳.角膜塑形镜延缓学生近视进展的临床研究.中华临床医师杂志(电子版)2015; 9(17):3230-3233
    16谢培英,王志昕,迟蕙.少年儿童近视的长期角膜塑形疗效和安全性观察.中国斜视与小儿眼科杂志 2008; 16(4):145-152
    17 Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, et al. Myopia control with orthokeratology contact lenses in Spain:refractive and biometric changes. Invest Ophthalmol Vis Sci 2012; 53(8):5060
    18 Walline JJ,Jones LA,Sinnott LT.Corneal reshaping and myopia progression. Br J Ophthalmol 2009; 93(9):1181
    19 Swarbrick HA,Wong G,O'Leary DJ.Corneal response to orthokeratology. Optom Vis Sci 1998; 75(11):791
    20 Walline JJ,Lindsley K,Vedula SS,et al. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev 2011; 12:CD004916
    21 Chua WH,Balakrishnan V,Chan YH,et al. Atropine for the treatment of childhood myopia. Ophthalmology 2006; 113(12):2285-2291
    22 Chia A,Chua WH,Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%,0.1%, and 0.01% doses(Atropine for the Treatment of Myopia 2). Ophthalmology 2012; 119(2):347-354
    23 Van Meter WS,Musch DC,Jacobs DS,et al. Safety of overnight orthokeratology for myopia:a report by the American Academy of Ophthalmology. Ophthalmology 2008; 115(12):2301-2313
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Zuo-Jie Zhang, Zhi-Qiang Hu, Min Shu,/et al.Efficacy and safety of orthokeratology to control myopia in Asia children: A Meta-analysis. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(2):248-251

Copy
Share
Article Metrics
  • Abstract:4319
  • PDF: 1298
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:May 23,2017
  • Revised:January 05,2018
  • Online: January 19,2018